Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5528-5536

  Motozono, Chihiro ^a   Yanaka, Saeko ^b   Tsumoto, Kouhei ^b   Takiguchi, Masafumi ^a   Ueno, Takamasa ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD4 ANTIGEN; EPITOPE; HLA B35 ANTIGEN; LEUCINE; METHIONINE; NEF PROTEIN; PEPTIDE; PROLINE; TYROSINE; VALINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL ACTIVITY; ARTICLE; CELL KILLING; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL SCANNING CALORIMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR HISTOCOMPATIBILITY COMPLEX; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; THERMODYNAMICS; VIRUS CELL INTERACTION; CELL CLONE; CELL LINE; CHEMISTRY; CYTOTOXICITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL LINE; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HIV ANTIGENS; HIV-1; HLA-B35 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDES; PROTEIN FOLDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; THERMODYNAMICS;

EID: 66949117887     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803471     Document Type: Article

References (58)

1. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
2. Saez-Cirion, A., C. Lacabaratz, O. Lambotte, P. Versmisse, A. Urrutia, F. Boufassa, F. Barre-Sinoussi, J.-F. Delfraissy, M. Sinet, G. Pancino, et al. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 104: 6776-6781. (Pubitemid 47175577)
3. + cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71: 3120-3128.
4. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13: 46-53.
5. Tomiyama, H., M. Fujiwara, S. Oka, and M. Takiguchi. 2005. Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J. Immunol. 174: 36-40. (Pubitemid 40007389)
6. Ueno, T., Y. Idegami, C. Motozono, S. Oka, and M. Takiguchi. 2007. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J. Immunol. 178: 5513-5523. (Pubitemid 46674346)
7. Yang, O. O., P. T. N. Sarkis, A. Trocha, S. A. Kalams, R. P. Johnson, and B. D. Walker. 2003. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL. J. Immunol. 171: 3718-3724.
8. Goulder, P. J. R., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, et al. 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193: 181-194.
9. Lichterfeld, M., X. G. Yu, D. Cohen, M. M. Addo, J. Malenfant, B. Perkins, E. Pae, M. N. Johnston, D. Strick, T. M. Allen, et al. 2004. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 18: 1383-1392. (Pubitemid 38925130)
10. Ueno, T., C. Motozono, S. Douki, P. Mwimanzi, S. Rauch, O. T. Fackler, S. Oka, and M. Takiguchi. 2008. CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef. J. Immunol. 180: 1107-1116.
11. Goulder, P. J. R., and D. I. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4: 630-640. (Pubitemid 39025048)
12. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
13. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
14. Dong, T., G. Stewart-Jones, N. Chen, P. Easterbrook, X. Xu, L. Papagno, V. Appay, M. Weekes, C. Conlon, C. Spina, et al. 2004. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J. Exp. Med. 200: 1547-1557. (Pubitemid 40094179)
15. Ueno, T., H. Tomiyama, M. Fujiwara, S. Oka, and M. Takiguchi. 2004. Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J. Immunol. 173: 5451-5457. (Pubitemid 39392129)
16. + T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J. Immunol. 176: 6130-6146.
17. Ali, A., R. Lubong, H. Ng, D. G. Brooks, J. A. Zack, and O. O. Yang. 2004. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J. Virol. 78: 561-567. (Pubitemid 38067577)
18. + T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178: 2746-2754.
19. van Baalen, C. A., C. Guillon, M. van Baalen, E. J. Verschuren, P. H. Boers, A. D. Osterhaus, and R. A. Gruters. 2002. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur. J. Immunol. 32: 2644-2652.
20. Le Gall, S., P. Stamegna, and B. D. Walker. 2007. Portable flanking sequences modulate CTL epitope processing. J. Clin. Invest. 117: 3563-3575. (Pubitemid 350097011)
21. + T-cell responses in acute HIV-1 infection: at the cross-roads of viral and host genetics. Trends Immunol. 26: 166-171.
22. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, and J. Ruppert. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153: 5586-5592. (Pubitemid 24377694)
23. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101. (Pubitemid 44264388)
24. Crotzer, V. L., R. E. Christian, J. M. Brooks, J. Shabanowitz, R. E. Settlage, J. A. Marto, F. M. White, A. B. Rickinson, D. F. Hunt, and V. H. Engelhard. 2000. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J. Immunol. 164: 6120-6129.
25. Frahm, N., P. Kiepiela, S. Adams, C. H. Linde, H. S. Hewitt, K. Sango, M. E. Feeney, M. M. Addo, M. Lichterfeld, M. P. Lahaie, et al. 2006. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat. Immunol. 7: 173-178. (Pubitemid 43135883)
26. + T cell responses. Immunity 25: 533-543.
27. Ueno, T., H. Tomiyama, M. Fujiwara, S. Oka, and M. Takiguchi. 2003. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor α chain having a Vδ1 variable segment. Eur. J. Immunol. 33: 2910-2916. (Pubitemid 37337157)
28. Ueno, T., H. Tomiyama, and M. Takiguchi. 2002. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. J. Immunol. 169: 4961-4969. (Pubitemid 35217162)
29. Kessels, H. W., M. D. van den Boom, H. Spits, E. Hooijberg, and T. N. M. Schumacher. 2000. Changing T cell specificity by retroviral T cell receptor display. Proc. Natl. Acad. Sci. USA 97: 14578-14583.
30. Yokosuka, T., K. Takase, M. Suzuki, Y. Nakagawa, S. Taki, H. Takahashi, T. Fujisawa, H. Arase, and T. Saito. 2002. Predominant role of T cell receptor (TCR)-α chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J. Exp. Med. 195: 991-1001. (Pubitemid 34412001)
31. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
32. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
33. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
34. Borbulevych, O. Y., T. K. Baxter, Z. Yu, N. P. Restifo, and B. M. Baker. 2005. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J. Immunol. 174: 4812-4820. (Pubitemid 40504564)
35. Fischer, A., S. Latour, and G. de Saint Basile. 2007. Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 19: 348-353. (Pubitemid 46705487)
36. Hillig, R. C., M. Hulsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler. 2004. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 279: 652-663.
37. Elliott, T., and A. Williams. 2005. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol. Rev. 207: 89-99. (Pubitemid 41415010)
38. van der Burg, S. H., M. J. Visseren, R. M. Brandt, W. M. Kast, and C. J. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156: 3308-3314.
39. Yu, Z., M. R. Theoret, C. E. Touloukian, D. R. Surman, S. C. Garman, L. Feigenbaum, T. K. Baxter, B. M. Baker, and N. P. Restifo. 2004. Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance. J. Clin. Invest. 114: 551-559. (Pubitemid 39572105)
40. Lazarski, C. A., F. A. Chaves, S. A. Jenks, S. Wu, K. A. Richards, J. M. Weaver, and A. J. Sant. 2005. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity 23: 29-40. (Pubitemid 41019655)
41. Sant, A. J., F. A. Chaves, S. A. Jenks, K. A. Richards, P. Menges, J. M. Weaver, and C. A. Lazarski. 2005. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207: 261-278. (Pubitemid 41415023)
42. Burrows, J. M., M. J. Bell, R. Brennan, J. J. Miles, R. Khanna, and S. R. Burrows. 2008. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition. Mol. Immunol. 45: 1818-1824.
43. Green, K. J., J. J. Miles, J. Tellam, W. J. van Zuylen, G. Connolly, and S. R. Burrows. 2004. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur. J. Immunol. 34: 2510-2519.
44. Probst-Kepper, M., H. J. Hecht, H. Herrmann, V. Janke, F. Ocklenburg, J. Klempnauer, B. J. van den Eynde, and S. Weiss. 2004. Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J. Immunol. 173: 5610-5616. (Pubitemid 39392148)
45. Probst-Kepper, M., V. Stroobant, R. Kridel, B. Gaugler, C. Landry, F. Brasseur, J. P. Cosyns, B. Weynand, T. Boon, and B. J. Van Den Eynde. 2001. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J. Exp. Med. 193: 1189-1198. (Pubitemid 32488371)
46. Collins, E. J., D. N. Garboczi, and D. C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371: 626-629.
47. Raghavan, M., N. Del Cid, S. M. Rizvi, and L. R. Peters. 2008. MHC class I assembly: out and about. Trends Immunol. 29: 436-443.
48. Wearsch, P. A., and P. Cresswell. 2008. The quality control of MHC class I peptide loading. Curr. Opin. Cell Biol. 20: 624-631.
49. Hulsmeyer, M., K. Welfle, T. Pohlmann, R. Misselwitz, U. Alexiev, H. Welfle, W. Saenger, B. Uchanska-Ziegler, and A. Ziegler. 2005. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J. Mol. Biol. 346: 1367-1379. (Pubitemid 40248835)
50. Abele, R., and R. Tamp. 2006. Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Letters 580: 1156-1163. (Pubitemid 43186039)
51. + T-cell immune responses? Immunol. Rev. 207: 77-88.
52. Daniel, S., V. Brusic, S. Caillat-Zucman, N. Petrovsky, L. Harrison, D. Riganelli, F. Sinigaglia, F. Gallazzi, J. Hammer, and P. M. van Endert. 1998. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol. 161: 617-624. (Pubitemid 28323522)
53. Peters, B., S. Bulik, R. Tampe, P. M. van Endert, and H.-G. Holzhutter. 2003. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J. Immunol. 171: 1741-1749. (Pubitemid 36966457)
54. Schatz, M. M., B. Peters, N. Akkad, N. Ullrich, A. N. Martinez, O. Carroll, S. Bulik, H.-G. Rammensee, P. van Endert, H.-G. Holzhutter, et al. 2008. Characterizing the N-terminal processing motif of MHC class I ligands. J. Immunol. 180: 3210-3217.
55. Kutsch, O., T. Vey, T. Kerkau, T. Hunig, and A. Schimpl. 2002. HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. AIDS Res. Hum. Retroviruses 18: 1319-1325. (Pubitemid 36042992)
56. Rammensse, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
57. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213. (Pubitemid 126349697)
58. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1: 59-64.